Aligned Genetics Inc - Asset Resilience Ratio

Latest as of September 2025: 2.22%

Aligned Genetics Inc (238120) has an Asset Resilience Ratio of 2.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 238120 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩1000.00 Million

≈ $677.69K USD Cash + Short-term Investments

Total Assets

₩45.11 Billion

≈ $30.57 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Aligned Genetics Inc's Asset Resilience Ratio has changed over time. See 238120 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Aligned Genetics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 238120 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1000.00 Million	2.22%
Total Liquid Assets	₩1000.00 Million	2.22%

Asset Resilience Insights

Limited Liquidity: Aligned Genetics Inc maintains only 2.22% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Aligned Genetics Inc Industry Peers by Asset Resilience Ratio

Compare Aligned Genetics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for Aligned Genetics Inc (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Aligned Genetics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	21.88%	₩9.69 Billion ≈ $6.56 Million	₩44.28 Billion ≈ $30.00 Million	+18.97pp
2023-12-31	2.90%	₩1.19 Billion ≈ $804.80K	₩40.93 Billion ≈ $27.74 Million	-8.63pp
2022-12-31	11.53%	₩4.25 Billion ≈ $2.88 Million	₩36.90 Billion ≈ $25.01 Million	-11.27pp
2021-12-31	22.80%	₩7.86 Billion ≈ $5.33 Million	₩34.47 Billion ≈ $23.36 Million	-24.84pp
2020-12-31	47.64%	₩12.14 Billion ≈ $8.23 Million	₩25.48 Billion ≈ $17.27 Million	-8.82pp
2019-12-31	56.46%	₩13.90 Billion ≈ $9.42 Million	₩24.62 Billion ≈ $16.68 Million	+26.38pp
2018-12-31	30.07%	₩6.92 Billion ≈ $4.69 Million	₩23.00 Billion ≈ $15.59 Million	-50.19pp
2017-12-31	80.26%	₩19.51 Billion ≈ $13.22 Million	₩24.31 Billion ≈ $16.47 Million	-3.13pp
2016-12-31	83.39%	₩21.56 Billion ≈ $14.61 Million	₩25.86 Billion ≈ $17.53 Million	+79.15pp
2015-12-31	4.23%	₩290.44 Million ≈ $196.83K	₩6.86 Billion ≈ $4.65 Million	--

pp = percentage points

About Aligned Genetics Inc

KQ:238120 Korea Medical Devices

Market Cap

$32.15 Million

₩47.45 Billion KRW

Market Cap Rank

#23571 Global

#1597 in Korea

Share Price

₩3375.00

Change (1 day)

+1.66%

52-Week Range

₩3080.00 - ₩6050.00

All Time High

₩7875.00